The orthopaedic genome: What does the future hold and are we ready?

Journal of Bone and Joint Surgery

Volumn 84, Issue 1, 2002, Pages 133-141

  Puzas, J Edward ^a   O'Keefe, Regis J ^a   Lieberman, Jay R ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DISEASE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; MEDICAL GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0036053470     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200201000-00019     Document Type: Review

References (24)

1. The parathyroid hormone-related protein
2. Bone morphogenetic proteins: From basic science to clinical applications
3. Role of parathyroid hormone-related peptide and Indian hedgehog in skeletal development
4. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
5. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
6. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
7. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
8. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
9. Cbfa1: A molecular switch in osteoblast biology
10. Role of Cbfa1 in osteoblast differentiation and function
11. Effect of long-term recombinant growth hormone therapy in children - The National Cooperative Growth Study, USA, 1985-1994
12. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation
13. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells
14. Genomic analysis of metastasis reveals an essential role for RhoC
15. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
16. Shattuck lecture - Medical and societal consequences of the Human Genome Project
17. Gene and stem cell therapies
18. Ethical issues of human germ-cell therapy: A preparation for public discussion
19. Protecting research subjects - What must be done
20. Medical ethics. Principles for human gene therapy studies
21. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch
22. The orthopaedic surgeon and industry. Ethics and industry incentives
23. Unnatural selection